Back to News
Market Impact: 0.1
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
Source: globenewswire.com
Management & GovernanceHealthcare & Biotech
CRISPR Therapeutics appointed Sivakesava (Siva) Sakhamuri, Ph.D., as chief technical officer, effective immediately.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
CRSP0.25
More News
- Apple Forecast Tops Estimates, Disappoints Investors
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Apple Sales Meet Estimates, China Is a Weak Spot
- OpenAI deepens Abu Dhabi foothold as Sam Altman inks deals spanning energy, government and investment
- RA Capital Management sells $9.13M in Lenz Therapeutics shares
- Karyopharm stock rating cut to neutral by Rodman on bankruptcy